论文部分内容阅读
喉癌病人最好在具有各种治疗设备并有帮助功能重建的中心来处理。虽然近代的治疗方案尚不统一,但可简单地分成三组: 第Ⅰ组:肿瘤局限于喉部,与周围组织无粘连固定,此组又可分为声门区和声门上区两类:声门癌的治疗首选放疗,其5年生存率为92％,烟、酒可降低疗效。局部和远处转移率小于5％,而复发率达22％。声门上区分声门上型(supraglottic)和边缘型(marginal):声门上型包括会厌下部、室带和喉室。30％的患者在诊断时可扪得颈淋巴结,还有20％虽已有颈淋巴结转移但未扪及。大部分适用水平喉部分切除术加颈淋巴结
Patients with laryngeal cancer are best treated in centers that have a variety of treatment equipment and help rebuild the function. Although modern treatment options are not yet uniform, they can be divided into three groups: Group I: Tumors are confined to the larynx, and there is no adhesion to the surrounding tissue. This group can be divided into two categories: glottic region and supraglottic region. : Radiotherapy for glottic cancer is preferred. The 5-year survival rate is 92%. Smoke and alcohol can reduce the curative effect. The rate of local and distant metastases is less than 5%, and the recurrence rate is 22%. Supraglottic and marginal are distinguished on the glottis: supraglottic types include the lower epiglottis, ventricular bands, and larynx. 30% of patients can get cervical lymph nodes at the time of diagnosis, and 20% have cervical lymph node metastasis but they are not affected. Most applicable horizontal partial laryngectomy plus cervical lymph nodes